JOINT FILING AGREEMENTJoint Filing Agreement • November 9th, 2020 • Thomvest Asset Management Ltd. • Pharmaceutical preparations
This will confirm the agreement among the undersigned that the Schedule 13D filed on or about this date and any amendments thereto with respect to beneficial ownership by the undersigned of the common shares, no par value, of Liminal Biosciences Inc. is being filed on behalf of each of the undersigned in accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
